nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—CYP3A4—Temozolomide—brain cancer	0.118	0.417	CbGbCtD
Dihydroergotamine—CYP3A4—Lomustine—brain cancer	0.1	0.354	CbGbCtD
Dihydroergotamine—HTR1D—meninx—brain cancer	0.0501	0.132	CbGeAlD
Dihydroergotamine—HTR1B—dura mater—brain cancer	0.0476	0.125	CbGeAlD
Dihydroergotamine—HTR1D—dura mater—brain cancer	0.0461	0.121	CbGeAlD
Dihydroergotamine—ABCB1—Etoposide—brain cancer	0.0405	0.143	CbGbCtD
Dihydroergotamine—CYP3A4—Etoposide—brain cancer	0.0243	0.0857	CbGbCtD
Dihydroergotamine—HTR1B—trigeminal nerve—brain cancer	0.0205	0.0539	CbGeAlD
Dihydroergotamine—HTR1D—trigeminal nerve—brain cancer	0.0198	0.0522	CbGeAlD
Dihydroergotamine—HTR1B—cranial nerve—brain cancer	0.0146	0.0384	CbGeAlD
Dihydroergotamine—HTR1D—cranial nerve—brain cancer	0.0141	0.0372	CbGeAlD
Dihydroergotamine—HTR6—ganglion—brain cancer	0.0122	0.0322	CbGeAlD
Dihydroergotamine—HTR1B—telencephalic ventricle—brain cancer	0.0119	0.0312	CbGeAlD
Dihydroergotamine—HTR1D—telencephalic ventricle—brain cancer	0.0115	0.0302	CbGeAlD
Dihydroergotamine—HTR1A—telencephalic ventricle—brain cancer	0.00957	0.0252	CbGeAlD
Dihydroergotamine—Vasospasm—Carmustine—brain cancer	0.00812	0.0241	CcSEcCtD
Dihydroergotamine—HTR1B—ganglion—brain cancer	0.00738	0.0194	CbGeAlD
Dihydroergotamine—HTR1D—ganglion—brain cancer	0.00715	0.0188	CbGeAlD
Dihydroergotamine—HTR1A—ganglion—brain cancer	0.00596	0.0157	CbGeAlD
Dihydroergotamine—HTR1B—blood vessel—brain cancer	0.00587	0.0154	CbGeAlD
Dihydroergotamine—HTR1D—blood vessel—brain cancer	0.00568	0.015	CbGeAlD
Dihydroergotamine—Petechiae—Procarbazine—brain cancer	0.00539	0.016	CcSEcCtD
Dihydroergotamine—HTR6—telencephalon—brain cancer	0.00472	0.0124	CbGeAlD
Dihydroergotamine—Cerebration impaired—Temozolomide—brain cancer	0.00456	0.0135	CcSEcCtD
Dihydroergotamine—HTR1A—hindbrain—brain cancer	0.00452	0.0119	CbGeAlD
Dihydroergotamine—Photophobia—Procarbazine—brain cancer	0.00416	0.0124	CcSEcCtD
Dihydroergotamine—Parosmia—Temozolomide—brain cancer	0.00413	0.0123	CcSEcCtD
Dihydroergotamine—Influenza-like symptoms—Temozolomide—brain cancer	0.00375	0.0112	CcSEcCtD
Dihydroergotamine—Stupor—Carmustine—brain cancer	0.00372	0.011	CcSEcCtD
Dihydroergotamine—Visual impairment—Lomustine—brain cancer	0.00338	0.01	CcSEcCtD
Dihydroergotamine—Rigors—Temozolomide—brain cancer	0.00328	0.00976	CcSEcCtD
Dihydroergotamine—Petechiae—Temozolomide—brain cancer	0.00326	0.00968	CcSEcCtD
Dihydroergotamine—Speech disorder—Carmustine—brain cancer	0.00323	0.00958	CcSEcCtD
Dihydroergotamine—HTR1B—brainstem—brain cancer	0.00321	0.00844	CbGeAlD
Dihydroergotamine—Speech disorder—Temozolomide—brain cancer	0.00312	0.00926	CcSEcCtD
Dihydroergotamine—HTR1D—brainstem—brain cancer	0.00311	0.00818	CbGeAlD
Dihydroergotamine—Disturbance in attention—Temozolomide—brain cancer	0.00309	0.00919	CcSEcCtD
Dihydroergotamine—HTR6—head—brain cancer	0.00294	0.00774	CbGeAlD
Dihydroergotamine—Herpes simplex—Temozolomide—brain cancer	0.00291	0.00864	CcSEcCtD
Dihydroergotamine—HTR1B—telencephalon—brain cancer	0.00285	0.00749	CbGeAlD
Dihydroergotamine—Gait disturbance—Carmustine—brain cancer	0.00284	0.00844	CcSEcCtD
Dihydroergotamine—Dysphagia—Procarbazine—brain cancer	0.00278	0.00826	CcSEcCtD
Dihydroergotamine—HTR1D—telencephalon—brain cancer	0.00276	0.00726	CbGeAlD
Dihydroergotamine—Gait disturbance—Temozolomide—brain cancer	0.00275	0.00816	CcSEcCtD
Dihydroergotamine—Angina pectoris—Procarbazine—brain cancer	0.00271	0.00805	CcSEcCtD
Dihydroergotamine—Sweating increased—Procarbazine—brain cancer	0.00271	0.00805	CcSEcCtD
Dihydroergotamine—HTR6—central nervous system—brain cancer	0.00269	0.00707	CbGeAlD
Dihydroergotamine—Vaginal inflammation—Temozolomide—brain cancer	0.00268	0.00797	CcSEcCtD
Dihydroergotamine—Depressed level of consciousness—Carmustine—brain cancer	0.00268	0.00796	CcSEcCtD
Dihydroergotamine—Tingling sensation—Etoposide—brain cancer	0.00267	0.00793	CcSEcCtD
Dihydroergotamine—Rigors—Etoposide—brain cancer	0.00263	0.00781	CcSEcCtD
Dihydroergotamine—Influenza like illness—Temozolomide—brain cancer	0.0026	0.00774	CcSEcCtD
Dihydroergotamine—HTR1A—brainstem—brain cancer	0.00259	0.00681	CbGeAlD
Dihydroergotamine—Depressed level of consciousness—Temozolomide—brain cancer	0.00259	0.00769	CcSEcCtD
Dihydroergotamine—Pollakiuria—Procarbazine—brain cancer	0.00257	0.00764	CcSEcCtD
Dihydroergotamine—HTR2B—telencephalon—brain cancer	0.00256	0.00675	CbGeAlD
Dihydroergotamine—Vaginal infection—Temozolomide—brain cancer	0.00253	0.00752	CcSEcCtD
Dihydroergotamine—Pain—Carboplatin—brain cancer	0.00244	0.00724	CcSEcCtD
Dihydroergotamine—Abnormal vision—Carmustine—brain cancer	0.00242	0.00719	CcSEcCtD
Dihydroergotamine—Mental disability—Carmustine—brain cancer	0.00241	0.00715	CcSEcCtD
Dihydroergotamine—Face oedema—Hydroxyurea—brain cancer	0.0024	0.00714	CcSEcCtD
Dihydroergotamine—Anorexia—Lomustine—brain cancer	0.00238	0.00706	CcSEcCtD
Dihydroergotamine—Epistaxis—Procarbazine—brain cancer	0.00234	0.00695	CcSEcCtD
Dihydroergotamine—Abnormal vision—Temozolomide—brain cancer	0.00234	0.00695	CcSEcCtD
Dihydroergotamine—Mental disability—Temozolomide—brain cancer	0.00233	0.00691	CcSEcCtD
Dihydroergotamine—HTR1A—telencephalon—brain cancer	0.0023	0.00605	CbGeAlD
Dihydroergotamine—Swelling—Carmustine—brain cancer	0.00228	0.00678	CcSEcCtD
Dihydroergotamine—Ear pain—Temozolomide—brain cancer	0.00228	0.00678	CcSEcCtD
Dihydroergotamine—Body temperature increased—Carboplatin—brain cancer	0.00225	0.00669	CcSEcCtD
Dihydroergotamine—Eye pain—Carmustine—brain cancer	0.00223	0.00663	CcSEcCtD
Dihydroergotamine—Injury—Carmustine—brain cancer	0.00219	0.00651	CcSEcCtD
Dihydroergotamine—Decreased appetite—Lomustine—brain cancer	0.00217	0.00644	CcSEcCtD
Dihydroergotamine—Eye pain—Temozolomide—brain cancer	0.00216	0.0064	CcSEcCtD
Dihydroergotamine—HTR6—brain—brain cancer	0.00213	0.00561	CbGeAlD
Dihydroergotamine—Hot flush—Temozolomide—brain cancer	0.00208	0.00618	CcSEcCtD
Dihydroergotamine—Flushing—Procarbazine—brain cancer	0.00207	0.00614	CcSEcCtD
Dihydroergotamine—Menopausal symptoms—Temozolomide—brain cancer	0.00206	0.00613	CcSEcCtD
Dihydroergotamine—HTR1B—midbrain—brain cancer	0.00204	0.00538	CbGeAlD
Dihydroergotamine—Chills—Procarbazine—brain cancer	0.002	0.00594	CcSEcCtD
Dihydroergotamine—HTR1B—spinal cord—brain cancer	0.002	0.00525	CbGeAlD
Dihydroergotamine—HTR1D—midbrain—brain cancer	0.00198	0.00521	CbGeAlD
Dihydroergotamine—Body temperature increased—Lomustine—brain cancer	0.00197	0.00585	CcSEcCtD
Dihydroergotamine—Face oedema—Carmustine—brain cancer	0.00194	0.00578	CcSEcCtD
Dihydroergotamine—Tension—Procarbazine—brain cancer	0.0019	0.00565	CcSEcCtD
Dihydroergotamine—Nervousness—Procarbazine—brain cancer	0.00188	0.00559	CcSEcCtD
Dihydroergotamine—Face oedema—Temozolomide—brain cancer	0.00188	0.00558	CcSEcCtD
Dihydroergotamine—ABCB1—blood vessel—brain cancer	0.00185	0.00487	CbGeAlD
Dihydroergotamine—Tremor—Procarbazine—brain cancer	0.00182	0.0054	CcSEcCtD
Dihydroergotamine—HTR1B—endocrine gland—brain cancer	0.0018	0.00473	CbGeAlD
Dihydroergotamine—Muscular weakness—Carmustine—brain cancer	0.00178	0.00528	CcSEcCtD
Dihydroergotamine—HTR1B—head—brain cancer	0.00177	0.00467	CbGeAlD
Dihydroergotamine—Swelling—Etoposide—brain cancer	0.00177	0.00524	CcSEcCtD
Dihydroergotamine—Dysphagia—Carmustine—brain cancer	0.00174	0.00517	CcSEcCtD
Dihydroergotamine—HTR1D—head—brain cancer	0.00172	0.00452	CbGeAlD
Dihydroergotamine—Muscular weakness—Temozolomide—brain cancer	0.00172	0.0051	CcSEcCtD
Dihydroergotamine—Dysphagia—Temozolomide—brain cancer	0.00168	0.005	CcSEcCtD
Dihydroergotamine—Hypertension—Procarbazine—brain cancer	0.00167	0.00497	CcSEcCtD
Dihydroergotamine—Arthralgia—Procarbazine—brain cancer	0.00165	0.0049	CcSEcCtD
Dihydroergotamine—Myalgia—Procarbazine—brain cancer	0.00165	0.0049	CcSEcCtD
Dihydroergotamine—HTR1A—midbrain—brain cancer	0.00165	0.00434	CbGeAlD
Dihydroergotamine—Anxiety—Procarbazine—brain cancer	0.00164	0.00489	CcSEcCtD
Dihydroergotamine—Sweating increased—Temozolomide—brain cancer	0.00164	0.00487	CcSEcCtD
Dihydroergotamine—HTR1B—central nervous system—brain cancer	0.00162	0.00426	CbGeAlD
Dihydroergotamine—Bronchitis—Temozolomide—brain cancer	0.00162	0.00481	CcSEcCtD
Dihydroergotamine—Dry mouth—Procarbazine—brain cancer	0.00161	0.00479	CcSEcCtD
Dihydroergotamine—ADRA2A—telencephalon—brain cancer	0.00161	0.00424	CbGeAlD
Dihydroergotamine—HTR1A—spinal cord—brain cancer	0.00161	0.00424	CbGeAlD
Dihydroergotamine—HTR2B—head—brain cancer	0.0016	0.0042	CbGeAlD
Dihydroergotamine—Confusional state—Procarbazine—brain cancer	0.0016	0.00474	CcSEcCtD
Dihydroergotamine—Vomiting—Lomustine—brain cancer	0.00158	0.00471	CcSEcCtD
Dihydroergotamine—Oedema—Procarbazine—brain cancer	0.00158	0.0047	CcSEcCtD
Dihydroergotamine—HTR1D—central nervous system—brain cancer	0.00157	0.00412	CbGeAlD
Dihydroergotamine—Upper respiratory tract infection—Temozolomide—brain cancer	0.00156	0.00464	CcSEcCtD
Dihydroergotamine—Shock—Procarbazine—brain cancer	0.00156	0.00462	CcSEcCtD
Dihydroergotamine—Pollakiuria—Temozolomide—brain cancer	0.00155	0.00462	CcSEcCtD
Dihydroergotamine—Chills—Hydroxyurea—brain cancer	0.00155	0.00459	CcSEcCtD
Dihydroergotamine—Tachycardia—Procarbazine—brain cancer	0.00154	0.00459	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Procarbazine—brain cancer	0.00153	0.00454	CcSEcCtD
Dihydroergotamine—Anorexia—Procarbazine—brain cancer	0.00151	0.00448	CcSEcCtD
Dihydroergotamine—Nausea—Lomustine—brain cancer	0.00148	0.0044	CcSEcCtD
Dihydroergotamine—Hypotension—Procarbazine—brain cancer	0.00148	0.00439	CcSEcCtD
Dihydroergotamine—HTR2B—central nervous system—brain cancer	0.00146	0.00384	CbGeAlD
Dihydroergotamine—HTR1A—endocrine gland—brain cancer	0.00145	0.00381	CbGeAlD
Dihydroergotamine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00144	0.00428	CcSEcCtD
Dihydroergotamine—HTR1A—head—brain cancer	0.00143	0.00377	CbGeAlD
Dihydroergotamine—Insomnia—Procarbazine—brain cancer	0.00143	0.00425	CcSEcCtD
Dihydroergotamine—Paraesthesia—Procarbazine—brain cancer	0.00142	0.00422	CcSEcCtD
Dihydroergotamine—Sinusitis—Temozolomide—brain cancer	0.00141	0.00418	CcSEcCtD
Dihydroergotamine—Somnolence—Procarbazine—brain cancer	0.00141	0.00418	CcSEcCtD
Dihydroergotamine—Cramp muscle—Etoposide—brain cancer	0.0014	0.00417	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Hydroxyurea—brain cancer	0.00139	0.00414	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Carmustine—brain cancer	0.00139	0.00412	CcSEcCtD
Dihydroergotamine—Decreased appetite—Procarbazine—brain cancer	0.00138	0.00409	CcSEcCtD
Dihydroergotamine—Fatigue—Procarbazine—brain cancer	0.00136	0.00405	CcSEcCtD
Dihydroergotamine—Malaise—Hydroxyurea—brain cancer	0.00135	0.00402	CcSEcCtD
Dihydroergotamine—Pain—Procarbazine—brain cancer	0.00135	0.00402	CcSEcCtD
Dihydroergotamine—Dysphagia—Etoposide—brain cancer	0.00135	0.004	CcSEcCtD
Dihydroergotamine—ADRA2A—gonad—brain cancer	0.00134	0.00354	CbGeAlD
Dihydroergotamine—Visual impairment—Carmustine—brain cancer	0.00134	0.00399	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Temozolomide—brain cancer	0.00134	0.00398	CcSEcCtD
Dihydroergotamine—Pharyngitis—Temozolomide—brain cancer	0.00134	0.00397	CcSEcCtD
Dihydroergotamine—Bronchospasm—Etoposide—brain cancer	0.00132	0.00393	CcSEcCtD
Dihydroergotamine—ADRA2A—pituitary gland—brain cancer	0.00131	0.00345	CbGeAlD
Dihydroergotamine—Sweating increased—Etoposide—brain cancer	0.00131	0.0039	CcSEcCtD
Dihydroergotamine—HTR1A—central nervous system—brain cancer	0.00131	0.00344	CbGeAlD
Dihydroergotamine—Feeling abnormal—Procarbazine—brain cancer	0.0013	0.00387	CcSEcCtD
Dihydroergotamine—Visual impairment—Temozolomide—brain cancer	0.0013	0.00385	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Procarbazine—brain cancer	0.00129	0.00384	CcSEcCtD
Dihydroergotamine—Flushing—Carmustine—brain cancer	0.00129	0.00384	CcSEcCtD
Dihydroergotamine—HTR1B—brain—brain cancer	0.00128	0.00338	CbGeAlD
Dihydroergotamine—HTR1A—cerebellum—brain cancer	0.00128	0.00336	CbGeAlD
Dihydroergotamine—ADRA2A—medulla oblongata—brain cancer	0.00127	0.00333	CbGeAlD
Dihydroergotamine—Discomfort—Hydroxyurea—brain cancer	0.00126	0.00375	CcSEcCtD
Dihydroergotamine—Urticaria—Procarbazine—brain cancer	0.00126	0.00373	CcSEcCtD
Dihydroergotamine—Tinnitus—Temozolomide—brain cancer	0.00126	0.00373	CcSEcCtD
Dihydroergotamine—Abdominal pain—Procarbazine—brain cancer	0.00125	0.00372	CcSEcCtD
Dihydroergotamine—Body temperature increased—Procarbazine—brain cancer	0.00125	0.00372	CcSEcCtD
Dihydroergotamine—Flushing—Temozolomide—brain cancer	0.00125	0.00371	CcSEcCtD
Dihydroergotamine—HTR1D—brain—brain cancer	0.00124	0.00327	CbGeAlD
Dihydroergotamine—Oedema—Hydroxyurea—brain cancer	0.00122	0.00364	CcSEcCtD
Dihydroergotamine—Chills—Temozolomide—brain cancer	0.00121	0.00359	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Etoposide—brain cancer	0.00118	0.00351	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Etoposide—brain cancer	0.00118	0.00349	CcSEcCtD
Dihydroergotamine—Anorexia—Hydroxyurea—brain cancer	0.00117	0.00347	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Procarbazine—brain cancer	0.00117	0.00346	CcSEcCtD
Dihydroergotamine—HTR2B—brain—brain cancer	0.00116	0.00305	CbGeAlD
Dihydroergotamine—ADRA2A—midbrain—brain cancer	0.00116	0.00304	CbGeAlD
Dihydroergotamine—Tremor—Carmustine—brain cancer	0.00114	0.00338	CcSEcCtD
Dihydroergotamine—Asthenia—Procarbazine—brain cancer	0.00114	0.00337	CcSEcCtD
Dihydroergotamine—ADRA2A—spinal cord—brain cancer	0.00113	0.00297	CbGeAlD
Dihydroergotamine—Pruritus—Procarbazine—brain cancer	0.00112	0.00333	CcSEcCtD
Dihydroergotamine—Agitation—Carmustine—brain cancer	0.00111	0.00331	CcSEcCtD
Dihydroergotamine—Tremor—Temozolomide—brain cancer	0.0011	0.00326	CcSEcCtD
Dihydroergotamine—Dyspnoea—Hydroxyurea—brain cancer	0.00109	0.00324	CcSEcCtD
Dihydroergotamine—Somnolence—Hydroxyurea—brain cancer	0.00109	0.00323	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Temozolomide—brain cancer	0.00109	0.00323	CcSEcCtD
Dihydroergotamine—Diarrhoea—Procarbazine—brain cancer	0.00108	0.00322	CcSEcCtD
Dihydroergotamine—Dyspepsia—Hydroxyurea—brain cancer	0.00108	0.0032	CcSEcCtD
Dihydroergotamine—Agitation—Temozolomide—brain cancer	0.00108	0.0032	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Etoposide—brain cancer	0.00107	0.00318	CcSEcCtD
Dihydroergotamine—Decreased appetite—Hydroxyurea—brain cancer	0.00106	0.00316	CcSEcCtD
Dihydroergotamine—Malaise—Temozolomide—brain cancer	0.00106	0.00314	CcSEcCtD
Dihydroergotamine—Fatigue—Hydroxyurea—brain cancer	0.00106	0.00314	CcSEcCtD
Dihydroergotamine—Vertigo—Temozolomide—brain cancer	0.00105	0.00313	CcSEcCtD
Dihydroergotamine—Hypertension—Carmustine—brain cancer	0.00105	0.00311	CcSEcCtD
Dihydroergotamine—Pain—Hydroxyurea—brain cancer	0.00105	0.00311	CcSEcCtD
Dihydroergotamine—Dizziness—Procarbazine—brain cancer	0.00105	0.00311	CcSEcCtD
Dihydroergotamine—HTR1A—brain—brain cancer	0.00104	0.00273	CbGeAlD
Dihydroergotamine—Palpitations—Temozolomide—brain cancer	0.00104	0.00308	CcSEcCtD
Dihydroergotamine—Myalgia—Carmustine—brain cancer	0.00103	0.00307	CcSEcCtD
Dihydroergotamine—Anxiety—Carmustine—brain cancer	0.00103	0.00306	CcSEcCtD
Dihydroergotamine—ADRA2A—endocrine gland—brain cancer	0.00102	0.00267	CbGeAlD
Dihydroergotamine—Hypertension—Temozolomide—brain cancer	0.00101	0.00301	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Hydroxyurea—brain cancer	0.00101	0.003	CcSEcCtD
Dihydroergotamine—Vomiting—Procarbazine—brain cancer	0.00101	0.00299	CcSEcCtD
Dihydroergotamine—ADRA2A—head—brain cancer	0.001	0.00264	CbGeAlD
Dihydroergotamine—Flushing—Etoposide—brain cancer	0.001	0.00297	CcSEcCtD
Dihydroergotamine—Confusional state—Carmustine—brain cancer	0.000998	0.00296	CcSEcCtD
Dihydroergotamine—Myalgia—Temozolomide—brain cancer	0.000998	0.00296	CcSEcCtD
Dihydroergotamine—Arthralgia—Temozolomide—brain cancer	0.000998	0.00296	CcSEcCtD
Dihydroergotamine—Rash—Procarbazine—brain cancer	0.000997	0.00296	CcSEcCtD
Dihydroergotamine—Dermatitis—Procarbazine—brain cancer	0.000997	0.00296	CcSEcCtD
Dihydroergotamine—Anxiety—Temozolomide—brain cancer	0.000994	0.00295	CcSEcCtD
Dihydroergotamine—Headache—Procarbazine—brain cancer	0.000991	0.00294	CcSEcCtD
Dihydroergotamine—Oedema—Carmustine—brain cancer	0.00099	0.00294	CcSEcCtD
Dihydroergotamine—Discomfort—Temozolomide—brain cancer	0.000986	0.00293	CcSEcCtD
Dihydroergotamine—Dry mouth—Temozolomide—brain cancer	0.000976	0.0029	CcSEcCtD
Dihydroergotamine—Body temperature increased—Hydroxyurea—brain cancer	0.000968	0.00288	CcSEcCtD
Dihydroergotamine—Chills—Etoposide—brain cancer	0.000967	0.00287	CcSEcCtD
Dihydroergotamine—Tachycardia—Carmustine—brain cancer	0.000966	0.00287	CcSEcCtD
Dihydroergotamine—Confusional state—Temozolomide—brain cancer	0.000964	0.00287	CcSEcCtD
Dihydroergotamine—Oedema—Temozolomide—brain cancer	0.000956	0.00284	CcSEcCtD
Dihydroergotamine—Anorexia—Carmustine—brain cancer	0.000943	0.0028	CcSEcCtD
Dihydroergotamine—Nausea—Procarbazine—brain cancer	0.00094	0.00279	CcSEcCtD
Dihydroergotamine—Hypotension—Carmustine—brain cancer	0.000925	0.00275	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Temozolomide—brain cancer	0.000925	0.00275	CcSEcCtD
Dihydroergotamine—ADRA2A—central nervous system—brain cancer	0.000915	0.00241	CbGeAlD
Dihydroergotamine—Anorexia—Temozolomide—brain cancer	0.000912	0.00271	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Hydroxyurea—brain cancer	0.000902	0.00268	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000902	0.00268	CcSEcCtD
Dihydroergotamine—Muscle spasms—Etoposide—brain cancer	0.000902	0.00268	CcSEcCtD
Dihydroergotamine—ABCB1—telencephalon—brain cancer	0.000897	0.00236	CbGeAlD
Dihydroergotamine—Insomnia—Carmustine—brain cancer	0.000895	0.00266	CcSEcCtD
Dihydroergotamine—ADRA2A—cerebellum—brain cancer	0.000895	0.00235	CbGeAlD
Dihydroergotamine—Paraesthesia—Carmustine—brain cancer	0.000889	0.00264	CcSEcCtD
Dihydroergotamine—Dyspnoea—Carmustine—brain cancer	0.000882	0.00262	CcSEcCtD
Dihydroergotamine—Somnolence—Carmustine—brain cancer	0.00088	0.00261	CcSEcCtD
Dihydroergotamine—Asthenia—Hydroxyurea—brain cancer	0.000878	0.00261	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000871	0.00259	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Etoposide—brain cancer	0.00087	0.00259	CcSEcCtD
Dihydroergotamine—Insomnia—Temozolomide—brain cancer	0.000865	0.00257	CcSEcCtD
Dihydroergotamine—Decreased appetite—Carmustine—brain cancer	0.00086	0.00256	CcSEcCtD
Dihydroergotamine—Paraesthesia—Temozolomide—brain cancer	0.000859	0.00255	CcSEcCtD
Dihydroergotamine—Dyspnoea—Temozolomide—brain cancer	0.000853	0.00253	CcSEcCtD
Dihydroergotamine—Somnolence—Temozolomide—brain cancer	0.00085	0.00253	CcSEcCtD
Dihydroergotamine—Pain—Carmustine—brain cancer	0.000846	0.00251	CcSEcCtD
Dihydroergotamine—Malaise—Etoposide—brain cancer	0.000846	0.00251	CcSEcCtD
Dihydroergotamine—Vertigo—Etoposide—brain cancer	0.000843	0.0025	CcSEcCtD
Dihydroergotamine—Dyspepsia—Temozolomide—brain cancer	0.000842	0.0025	CcSEcCtD
Dihydroergotamine—Diarrhoea—Hydroxyurea—brain cancer	0.000838	0.00249	CcSEcCtD
Dihydroergotamine—Decreased appetite—Temozolomide—brain cancer	0.000831	0.00247	CcSEcCtD
Dihydroergotamine—Fatigue—Temozolomide—brain cancer	0.000825	0.00245	CcSEcCtD
Dihydroergotamine—Pain—Temozolomide—brain cancer	0.000818	0.00243	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Carmustine—brain cancer	0.000816	0.00242	CcSEcCtD
Dihydroergotamine—Hypertension—Etoposide—brain cancer	0.00081	0.00241	CcSEcCtD
Dihydroergotamine—Dizziness—Hydroxyurea—brain cancer	0.00081	0.00241	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Carmustine—brain cancer	0.000809	0.0024	CcSEcCtD
Dihydroergotamine—CYP3A4—endocrine gland—brain cancer	0.0008	0.0021	CbGeAlD
Dihydroergotamine—Discomfort—Etoposide—brain cancer	0.000789	0.00234	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Temozolomide—brain cancer	0.000788	0.00234	CcSEcCtD
Dihydroergotamine—Abdominal pain—Carmustine—brain cancer	0.000782	0.00232	CcSEcCtD
Dihydroergotamine—Body temperature increased—Carmustine—brain cancer	0.000782	0.00232	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Temozolomide—brain cancer	0.000782	0.00232	CcSEcCtD
Dihydroergotamine—Vomiting—Hydroxyurea—brain cancer	0.000778	0.00231	CcSEcCtD
Dihydroergotamine—Rash—Hydroxyurea—brain cancer	0.000772	0.00229	CcSEcCtD
Dihydroergotamine—Confusional state—Etoposide—brain cancer	0.000772	0.00229	CcSEcCtD
Dihydroergotamine—Dermatitis—Hydroxyurea—brain cancer	0.000771	0.00229	CcSEcCtD
Dihydroergotamine—Headache—Hydroxyurea—brain cancer	0.000767	0.00228	CcSEcCtD
Dihydroergotamine—Urticaria—Temozolomide—brain cancer	0.00076	0.00226	CcSEcCtD
Dihydroergotamine—Abdominal pain—Temozolomide—brain cancer	0.000756	0.00225	CcSEcCtD
Dihydroergotamine—Body temperature increased—Temozolomide—brain cancer	0.000756	0.00225	CcSEcCtD
Dihydroergotamine—ABCB1—gonad—brain cancer	0.000749	0.00197	CbGeAlD
Dihydroergotamine—Tachycardia—Etoposide—brain cancer	0.000747	0.00222	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Etoposide—brain cancer	0.00074	0.0022	CcSEcCtD
Dihydroergotamine—ABCB1—pituitary gland—brain cancer	0.000731	0.00192	CbGeAlD
Dihydroergotamine—Anorexia—Etoposide—brain cancer	0.00073	0.00217	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Carmustine—brain cancer	0.000729	0.00217	CcSEcCtD
Dihydroergotamine—Nausea—Hydroxyurea—brain cancer	0.000727	0.00216	CcSEcCtD
Dihydroergotamine—ADRA2A—brain—brain cancer	0.000727	0.00191	CbGeAlD
Dihydroergotamine—CYP3A4—central nervous system—brain cancer	0.000721	0.0019	CbGeAlD
Dihydroergotamine—Hypotension—Etoposide—brain cancer	0.000715	0.00212	CcSEcCtD
Dihydroergotamine—Asthenia—Carmustine—brain cancer	0.00071	0.00211	CcSEcCtD
Dihydroergotamine—ABCB1—medulla oblongata—brain cancer	0.000705	0.00186	CbGeAlD
Dihydroergotamine—Hypersensitivity—Temozolomide—brain cancer	0.000705	0.00209	CcSEcCtD
Dihydroergotamine—Paraesthesia—Etoposide—brain cancer	0.000687	0.00204	CcSEcCtD
Dihydroergotamine—Asthenia—Temozolomide—brain cancer	0.000686	0.00204	CcSEcCtD
Dihydroergotamine—Dyspnoea—Etoposide—brain cancer	0.000682	0.00203	CcSEcCtD
Dihydroergotamine—Somnolence—Etoposide—brain cancer	0.00068	0.00202	CcSEcCtD
Dihydroergotamine—Diarrhoea—Carmustine—brain cancer	0.000677	0.00201	CcSEcCtD
Dihydroergotamine—Pruritus—Temozolomide—brain cancer	0.000677	0.00201	CcSEcCtD
Dihydroergotamine—Decreased appetite—Etoposide—brain cancer	0.000665	0.00198	CcSEcCtD
Dihydroergotamine—Fatigue—Etoposide—brain cancer	0.00066	0.00196	CcSEcCtD
Dihydroergotamine—Dizziness—Carmustine—brain cancer	0.000654	0.00194	CcSEcCtD
Dihydroergotamine—Pain—Etoposide—brain cancer	0.000654	0.00194	CcSEcCtD
Dihydroergotamine—Diarrhoea—Temozolomide—brain cancer	0.000654	0.00194	CcSEcCtD
Dihydroergotamine—ABCB1—midbrain—brain cancer	0.000644	0.0017	CbGeAlD
Dihydroergotamine—Dizziness—Temozolomide—brain cancer	0.000632	0.00188	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Etoposide—brain cancer	0.000631	0.00187	CcSEcCtD
Dihydroergotamine—Vomiting—Carmustine—brain cancer	0.000629	0.00187	CcSEcCtD
Dihydroergotamine—ABCB1—spinal cord—brain cancer	0.000629	0.00165	CbGeAlD
Dihydroergotamine—Gastrointestinal pain—Etoposide—brain cancer	0.000626	0.00186	CcSEcCtD
Dihydroergotamine—Rash—Carmustine—brain cancer	0.000624	0.00185	CcSEcCtD
Dihydroergotamine—Dermatitis—Carmustine—brain cancer	0.000623	0.00185	CcSEcCtD
Dihydroergotamine—Headache—Carmustine—brain cancer	0.00062	0.00184	CcSEcCtD
Dihydroergotamine—Vomiting—Temozolomide—brain cancer	0.000608	0.00181	CcSEcCtD
Dihydroergotamine—Urticaria—Etoposide—brain cancer	0.000608	0.00181	CcSEcCtD
Dihydroergotamine—Body temperature increased—Etoposide—brain cancer	0.000605	0.0018	CcSEcCtD
Dihydroergotamine—Abdominal pain—Etoposide—brain cancer	0.000605	0.0018	CcSEcCtD
Dihydroergotamine—Rash—Temozolomide—brain cancer	0.000603	0.00179	CcSEcCtD
Dihydroergotamine—Dermatitis—Temozolomide—brain cancer	0.000603	0.00179	CcSEcCtD
Dihydroergotamine—Headache—Temozolomide—brain cancer	0.000599	0.00178	CcSEcCtD
Dihydroergotamine—Nausea—Carmustine—brain cancer	0.000588	0.00175	CcSEcCtD
Dihydroergotamine—Nausea—Temozolomide—brain cancer	0.000568	0.00169	CcSEcCtD
Dihydroergotamine—ABCB1—endocrine gland—brain cancer	0.000566	0.00149	CbGeAlD
Dihydroergotamine—Hypersensitivity—Etoposide—brain cancer	0.000564	0.00168	CcSEcCtD
Dihydroergotamine—ABCB1—head—brain cancer	0.000559	0.00147	CbGeAlD
Dihydroergotamine—Asthenia—Etoposide—brain cancer	0.000549	0.00163	CcSEcCtD
Dihydroergotamine—Pruritus—Etoposide—brain cancer	0.000541	0.00161	CcSEcCtD
Dihydroergotamine—Diarrhoea—Etoposide—brain cancer	0.000524	0.00156	CcSEcCtD
Dihydroergotamine—ABCB1—central nervous system—brain cancer	0.00051	0.00134	CbGeAlD
Dihydroergotamine—Dizziness—Etoposide—brain cancer	0.000506	0.0015	CcSEcCtD
Dihydroergotamine—ABCB1—cerebellum—brain cancer	0.000499	0.00131	CbGeAlD
Dihydroergotamine—Vomiting—Etoposide—brain cancer	0.000487	0.00145	CcSEcCtD
Dihydroergotamine—Rash—Etoposide—brain cancer	0.000483	0.00143	CcSEcCtD
Dihydroergotamine—Dermatitis—Etoposide—brain cancer	0.000482	0.00143	CcSEcCtD
Dihydroergotamine—Headache—Etoposide—brain cancer	0.000479	0.00142	CcSEcCtD
Dihydroergotamine—Nausea—Etoposide—brain cancer	0.000455	0.00135	CcSEcCtD
Dihydroergotamine—ABCB1—brain—brain cancer	0.000405	0.00107	CbGeAlD
